MICHELE NELSON PRIVETTE: Open Payments
NPI 1710018932 · VENICE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$417 in 18 payments from 8 companies in 2025. Trend: 2023 $307 · 2024 $772 · 2025 $417
Food & beverage: $417
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $119 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $118 |
| Axsome Therapeutics, Inc. | 3 | $71 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
Products named: VRAYLAR, TRINTELLIX, Auvelity, REXULTI, SPRAVATO, INGREZZA, FANAPT, Qelbree.
Industry payments across FL — which companies pay providers there.
